|
|
Volumn 1, Issue 3, 2012, Pages 261-262
|
|
The immune microenvironment as a guide for cancer therapies
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
CANCER VACCINE;
MONOCLONAL ANTIBODY;
ADVANCED CANCER;
ANTINEOPLASTIC ACTIVITY;
BREAST CANCER;
CANCER CONTROL;
CANCER IMMUNIZATION;
CANCER IMMUNOTHERAPY;
CANCER PROGNOSIS;
CANCER SURVIVAL;
CD8+ T LYMPHOCYTE;
COLORECTAL CANCER;
DRUG EFFICACY;
EDITORIAL;
HUMAN;
LYMPHOMA;
MEMORY T LYMPHOCYTE;
NONHUMAN;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
PROSTATE CANCER;
SURVIVAL PREDICTION;
TUMOR MICROENVIRONMENT;
|
|
EID: 84886944563
PISSN: 21624011
EISSN: 2162402X
Source Type: Journal
DOI: 10.4161/onci.19651 Document Type: Editorial |
|
Times cited : (19)
|
|
References (0)
|
